Anavex Life Sciences (AVXL) Current Assets (2011 - 2020)
Anavex Life Sciences (AVXL) posted Current Assets of $31.63 million for fiscal Q3 2020 (quarter ended Jun 30, 2020), up 45.0% from $21.82 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Current Assets (2011 - 2020) Analysis & Trends
At the end of FY2019 (ended Sep 30, 2019), Anavex Life Sciences' Current Assets came in at $25.33 million, down 2.8% from FY2018.
- Annual Current Assets shows a five-year compound annual growth rate of 28.1% (FY2014 to FY2019).
- In prior fiscal years, Anavex Life Sciences' Current Assets was $26.05 million in FY2018 (-6.2%), $27.79 million in FY2017 (+194.1%) and $9.45 million in FY2016.
- The fiscal Q3 2020 figure stands as the highest quarterly Current Assets in data going back to fiscal Q4 2011.
- On a year-over-year basis, Current Assets increased in 1 of the last six quarters, with an average decline of 4.1%.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q4 2017, with growth of 194.1%; the weakest was fiscal Q1 2019, with a decline of 21.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 31.63 Mn |
| Sep 30, 2019 | 25.33 Mn |
| Jun 30, 2019 | 21.82 Mn |
| Mar 31, 2019 | 20.55 Mn |
| Dec 31, 2018 | 22.10 Mn |
| Sep 30, 2018 | 26.05 Mn |
| Jun 30, 2018 | 26.74 Mn |
| Mar 31, 2018 | 25.81 Mn |
| Dec 31, 2017 | 28.29 Mn |
| Sep 30, 2017 | 27.79 Mn |
| Jun 30, 2017 | 24.85 Mn |
| Sep 30, 2016 | 9.45 Mn |
| Jun 30, 2015 | 7.98 Mn |
| Mar 31, 2015 | 6.36 Mn |
| Dec 31, 2014 | 7.05 Mn |
| Sep 30, 2014 | 7.35 Mn |
| Jun 30, 2014 | 8.20 Mn |
| Mar 31, 2014 | 9.22 Mn |
| Dec 31, 2013 | 148,752.00 |
| Sep 30, 2013 | 393,449.00 |
API Access
Anavex Life Sciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();